Toledano Helen, Muhsinoglu Orkun, Luckman Judith, Goldenberg-Cohen Nitza, Michowiz Shalom
Department of Pediatric Oncology, Schneider Children's Medical Center of Israel, Petach Tikva 49202, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Department of Ophthalmology, Rabin Medical Center, Petach Tikva 49100, Israel.
Eur J Paediatr Neurol. 2015 Nov;19(6):694-700. doi: 10.1016/j.ejpn.2015.06.007. Epub 2015 Jul 9.
BACKGROUND/PURPOSE: The aim of the study was to investigate the incidence of nystagmus at diagnosis in children with optic pathway glioma involving the chiasm and hypothalamus.
Twenty-two patients with a measurable optic pathway/hypothalamic glioma (without neurofibromatosis-1) were followed in our center from 2001 to 2013. The medical files were retrospectively reviewed for demographic and clinical findings, and the imaging scans, for tumor characteristics.
There were 9 boys and 13 girls of mean age 3.5 ± 4.4 years at diagnosis; 15 were aged <2 years. Tumor size ranged from 10 × 6 mm to 62 × 29 mm. Mean duration of follow-up was 8.3 ± 5.4 years. Nystagmus was detected at diagnosis in 10 children (45%), all <2 years old (66.6% of the younger group); no child older than 2 years presented with nystagmus. Nystagmus, once present, did not resolve and continued throughout follow-up. There were no cases of new onset of nystagmus during follow-up in the children in whom it was not detected at diagnosis. Treatment consisted of partial resection/biopsy with/without shunting (n = 13) and chemotherapy (n = 19) with (n = 2) or without adjuvant radiation. Of the 22 children, 6 had a radiographic response to treatment, 8 remained stable, and 8 (all of whom received chemotherapy) showed disease progression despite treatment.
In conclusion, monocular nystagmus is a more common presenting sign of optic pathway/hypothalamic glioma in children <2 years old than previously estimated. Although subtle, nystagmus has a very narrow differential diagnosis, and its presence should raise suspicions of a chiasmal tumor with prompt referral for imaging. The visual prognosis is moderate to poor.
背景/目的:本研究旨在调查累及视交叉和下丘脑的视神经胶质瘤患儿诊断时眼球震颤的发生率。
2001年至2013年,我们中心对22例可测量的视神经/下丘脑胶质瘤(无神经纤维瘤病1型)患者进行了随访。对病历进行回顾性分析,以获取人口统计学和临床资料,并对影像学扫描结果进行分析,以了解肿瘤特征。
诊断时,有9名男孩和13名女孩,平均年龄3.5±4.4岁;15名年龄小于2岁。肿瘤大小从10×6mm到62×29mm不等。平均随访时间为8.3±5.4年。10名儿童(45%)在诊断时被检测出眼球震颤,均小于2岁(占较年幼组的66.6%);2岁以上儿童无眼球震颤表现。眼球震颤一旦出现,不会缓解,并在整个随访过程中持续存在。诊断时未检测出眼球震颤的儿童在随访期间无新发眼球震颤病例。治疗包括部分切除/活检并伴有或不伴有分流术(n = 13)以及化疗(n = 19),化疗伴有(n = 2)或不伴有辅助放疗。22名儿童中,6名对治疗有影像学反应,8名病情稳定,8名(均接受了化疗)尽管接受了治疗仍显示疾病进展。
总之,单眼眼球震颤是2岁以下儿童视神经/下丘脑胶质瘤比先前估计更为常见的表现体征。尽管不明显,但眼球震颤的鉴别诊断范围非常窄,其出现应引起对视交叉肿瘤的怀疑,并应立即转诊进行影像学检查。视觉预后为中度至较差。